Professor Ramin Nilforooshan: key facts
- Kind of voice
- Clinician
- Role
- consultant psychiatrist and chief investigator for the PrevenTRON trial
- Quoted on
- Adult social care & reform, Dementia, Mental health
- Press citations held
- 7
- Most recently quoted
- 30 Sept 2026
- First quoted
- 29 Sept 2026
“We are very excited for the potential to help millions of people affected by Alzheimer's disease.”
What Professor Ramin Nilforooshan has said
“For decades, research has focused on treating Alzheimer's disease after symptoms appear. PrevenTron addresses a different question – whether we can act earlier, before symptoms begin.”
Chief investigator for the PrevenTron trial · Dementia · 30 Sept 2026 · Healthy middle-aged people offered Alzheimer’s drug in world-first trial ↗
“research had "for decades" focused on treating Alzheimer's after symptoms appeared. The trial "addresses a different question, whether we can act earlier, before symptoms begin"”
consultant psychiatrist and chief investigator for the trial · Dementia · 30 Sept 2026 · NHS trust joins Alzheimer’s prevention trial ↗
“For decades, research has focused on treating Alzheimer's disease after symptoms appear. PrevenTRON addresses a different question, whether we can act earlier, before symptoms begin.”
consultant psychiatrist and chief investigator for the PrevenTRON trial · Mental health · 29 Sept 2026 · Alzheimer’s trial to test drug on people without symptoms to see if it can be prevented ↗
“The trial "addresses a different question, whether we can act earlier, before symptoms begin". "We are very excited for the potential to help millions of people affected by Alzheimer's disease."”
consultant psychiatrist and chief investigator for the trial · Dementia · 29 Sept 2026 · NHS trust joins Alzheimer's prevention drug trial ↗
“For decades, research has focused on treating Alzheimer's disease after symptoms appear. PrevenTRON addresses a different question: whether we can act earlier, before symptoms begin. Through research and trials like PrevenTRON, we are very excited for the potential to help millions of people affected by Alzheimer's disease.”
psychiatry consultant at the University of Surrey · Dementia · 29 Sept 2026 · Major trial of Roche Alzheimer's drug kicks off in Europe ↗
“Being the first site across Europe and the third in the world to open PrevenTRON is a proud moment for our Research and Development team and for the communities we serve. For decades, research has focused on treating Alzheimer's disease after symptoms appear. PrevenTRON addresses a different question, whether we can act earlier, before symptoms begin.”
Consultant psychiatrist and Chief Investigator for PrevenTRON · Dementia · 29 Sept 2026 · Surrey and Borders Leads European Alzheimer’s Prevention Trial ↗
Where Professor Ramin Nilforooshan has been quoted
- ‘Dementia drug’ to be offered to over 55s in UKexpress.co.uk · 30 Sept 2026
- Healthy middle-aged people offered Alzheimer’s drug in world-first trialtelegraph.co.uk · 30 Sept 2026
- NHS trust joins Alzheimer’s prevention trialyahoo.com · 30 Sept 2026
- Alzheimer’s trial to test drug on people without symptoms to see if it can be preventedtheguardian.com · 29 Sept 2026
- NHS trust joins Alzheimer's prevention drug trialbbc.co.uk · 29 Sept 2026
- Major trial of Roche Alzheimer's drug kicks off in Europepharmaphorum.com · 29 Sept 2026
- Surrey and Borders Leads European Alzheimer’s Prevention Trialthecareruk.com · 29 Sept 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.